Lamivudine is recommended for treatment of chronic hepatitis B when:
**Core Concept**
Lamivudine is an antiviral medication used to treat chronic hepatitis B infection by inhibiting the replication of the hepatitis B virus (HBV). It works by blocking the viral DNA polymerase enzyme, which is essential for the viral replication process.
**Why the Correct Answer is Right**
Lamivudine is recommended for treatment of chronic hepatitis B when the liver enzyme levels (alanine transaminase, ALT) are elevated, indicating active liver inflammation. This is because lamivudine can help reduce liver enzyme levels and slow down the progression of liver fibrosis and cirrhosis. The mechanism of action involves the inhibition of the HBV DNA polymerase enzyme, which is a key enzyme responsible for the replication of the HBV genome.
**Why Each Wrong Option is Incorrect**
**Option A:** Lamivudine is not recommended for treatment of acute hepatitis B, as the body's immune response is often sufficient to clear the virus on its own.
**Option B:** Lamivudine is not a first-line treatment for chronic hepatitis B, as other antiviral medications such as entecavir and tenofovir are more effective.
**Option C:** Lamivudine is not indicated for treatment of hepatitis C, as it is specific to HBV replication.
**Clinical Pearl / High-Yield Fact**
It's essential to monitor liver enzyme levels regularly while on lamivudine treatment, as elevated levels may indicate the development of resistance to the medication.
**Correct Answer: C. Lamivudine is not a first-line treatment for chronic hepatitis B.**